Company Profile

Accelerated Medical Diagnostics LLC
Profile last edited on: 11/15/2019      CAGE: 549U4      UEI: JWEZE9VNHL14

Business Identifier: Personalizing chemotherapy with diagnostic microdosing
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

957 Hilldale Avenue
Berkeley, CA 94708
Location: Single
Congr. District: 12
County: Alameda

Public Profile

Accelerated Medical Diagnostics, Inc., is a cancer diagnostics company bringing together expertise in cancer biology, chemotherapy drugs and diagnostics to develop objective, reproducible tests designed to provide clinicians with information to enhance patient care. Early in the field of predictive chemotherapy diagnostics, the firm is stucrured around developing clinically validated tests that empower clinicians better to tailor care to each individual patient. In collaborations with university hospitals - UC Davis and UCSF - Accelerated Medical Diagnostics is currently conducting a retrospective clinical trial. The firm is strategically focused on induction chemotherapy for acute myeloid leukemia (AML) and close to commercialization of the firm's test - InductDx - that enables measurement of cellular responses to nontoxic “microdoses” of chemotherapy administered to cells derived from patient blood samples.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2017 1 NIH $299,999
Project Title: Feasibility of predicting AML response to induction chemotherapy
2012 2 NIH $1,695,444
Project Title: Phase 0 Carboplatin Microdosing Diagnostics Trial
2012 1 NIH $199,969
Project Title: Other Functions - R&D Biomedical (Basic Research)

Key People / Management

  Paul T Henderson -- Chief Executive Officer

  George Cimino -- VP of Development & CFO

  William Hope -- Financial Consultant

  Chong-Xian Pan -- Co Founder

  Neil Thompson -- Board of Directors

  Maike Zimmerman -- Postdoctoral Fellow